Literature DB >> 17129738

A mitochondrial-targeting signal is present in the non-catalytic domain of the MELK protein kinase.

Isabelle Chartrain1, Joëlle Blot, Hubert Lerivray, Nicolas Guyot, Jean-Pierre Tassan.   

Abstract

MELK is a cell cycle-regulated protein kinase involved in cell cycle progression, proliferation, tumor growth and mRNA splicing. MELK is localized in the cytoplasm and the nucleus during interphase and at the cell cortex during anaphase and telophase. In this report, we show that the regulatory domain of Xenopus MELK when tagged at its C-terminus with the green fluorescent protein (GFP), co-localizes with mitochondria in Xenopus XL2 cells. Significantly, the presence of a mitochondrial targeting signal at the N-terminus of this fusion protein was predicted by bioinformatics analyses. In agreement with previous reports on mitochondrial proteins, placing the GFP at the N-terminus inhibited the mitochondrial targeting of the MELK fragment and, furthermore, the regulatory domain without a tag co-localizes with mitochondria. These results demonstrate the presence of a mitochondrial targeting signal at the N-terminus of the MC domain of MELK. This mitochondrial targeting signal was also functional in human HeLa cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17129738     DOI: 10.1016/j.cellbi.2006.10.005

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  3 in total

1.  MELK expression in breast cancer is associated with infiltration of immune cell and pathological compete response (pCR) after neoadjuvant chemotherapy.

Authors:  Masanori Oshi; Shipra Gandhi; Michelle R Huyser; Yoshihisa Tokumaru; Li Yan; Akimitsu Yamada; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2021-09-15       Impact factor: 5.942

2.  OTSSP167 Abrogates Mitotic Checkpoint through Inhibiting Multiple Mitotic Kinases.

Authors:  Wenbin Ji; Christopher Arnst; Aaron R Tipton; Michael E Bekier; William R Taylor; Tim J Yen; Song-Tao Liu
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

3.  Stathmin involvement in the maternal embryonic leucine zipper kinase pathway in glioblastoma.

Authors:  Suely Kazue Nagahashi Marie; Sueli Mieko Oba-Shinjo; Roseli da Silva; Marcela Gimenez; Gisele Nunes Reis; Jean-Pierre Tassan; Jose Cesar Rosa; Miyuki Uno
Journal:  Proteome Sci       Date:  2016-03-11       Impact factor: 2.480

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.